The metabolic stone evaluation: An opportunity for shared decision-making
Keywords:kidney stone, metabolic evaluation, shared decision-making
AbstractN/A (it's an editorial/commentary on another paper)
Harmouch SS, Abou-Haidar H, Elhawary H, et al. Metabolic evaluation guidelines in patients with nephrolithiasis: Are they being followed? Results of a national, multi-institutional quality assessment study. Can Urol Assoc J 2018 May 28. doi: 10.5489/cuaj.5155. [Epub ahead of print]
Dion M, Ankawi G, Chew B, et al. CUA guideline on the evaluation and medical management of the kidney stone patient – 2016 update. Can Urol Assoc J 2016. 10: p. E347-E358.
Rule AD, Lieske JC, Li X, et al. The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol 2014 Dec;25(12):2878-86. doi: 10.1681/ASN.2013091011. Epub 2014 Aug 7.
Pearle MS, Calhoun EA, Curhan GC. Urologic diseases in America project: urolithiasis. J Urol 2005;173:848-57.
Bensalah K, Tuncel A, Gupta A, et al. Determinants of quality of life for patients with kidney stones. J Urol 2008 Jun;179(6):2238-43; discussion 2243. doi: 10.1016/j.juro.2008.01.116. Epub 2008 Apr 18.
Patel N, Brown RD, Sarkissian C, et al. Quality of life and urolithiasis: the patient - reported outcomes measurement information system (PROMIS). Int Braz J Urol 2017 Sep-Oct;43(5):880-886. doi: 10.1590/S1677-5538.IBJU.2016.0649.
Raffin EP, Penniston KL, Antonelli JA, et al. The effect of thiazide and potassium citrate use on the health-related quality of life of patients with urolithiasis. J Urol 2018 Jun 15. pii: S0022-5347(18)43402-7. doi: 10.1016/j.juro.2018.06.023. [Epub ahead of print]
Borghi L, Meschi T, Amato F, et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 1996 Mar;155(3):839-43.
Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002 Jan 10;346(2):77-84.
Barcelo P, Wuhl O, Servitge E, et al: Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 1993; 150: 1761.
Pearle MS, Roehrborn CG, Pak CY: Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol 1999;13:679-85.
Ettinger B, Tang A, Citron JT, et al. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 1986 Nov 27;315(22):1386-9.
Bensalah K, Tuncel A, Raman JD, et al. How physician and patient perceptions differ regarding medical management of stone disease. J Urol 2009 Sep;182(3):998-1004. doi: 10.1016/j.juro.2009.05.025. Epub 2009 Jul 18.
Matlaga BR. Are we correctly managing urinary calculi? J Urol 2009 Sep;182(3):826-7. doi: 10.1016/j.juro.2009.06.072. Epub 2009 Jul 17.
How to Cite
You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:
- Post the Article on any Web site
- Translate or authorize a translation of the Article
- Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
- Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.
The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.
You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.
The CUA also requires you to warrant the following:
- That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
- That all individuals who have made a substantive contribution to the article are acknowledged;
- That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
- That the Article does not libel or violate the privacy rights of any third party.